A detailed history of Sumitomo Mitsui Ds Asset Management Company, LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sumitomo Mitsui Ds Asset Management Company, LTD holds 622,023 shares of MRK stock, worth $59.9 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares
622,023
Previous 564,825 10.13%
Holding current value
$59.9 Million
Previous $69.9 Million 1.02%
% of portfolio
0.77%
Previous 0.83%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$111.15 - $128.97 $6.36 Million - $7.38 Million
57,198 Added 10.13%
622,023 $70.6 Million
Q2 2024

Jul 30, 2024

BUY
$123.8 - $132.96 $1.94 Million - $2.08 Million
15,650 Added 2.85%
564,825 $69.9 Million
Q1 2024

May 02, 2024

BUY
$113.24 - $131.95 $2.6 Million - $3.03 Million
22,950 Added 4.36%
549,175 $72.5 Million
Q4 2023

Feb 01, 2024

SELL
$100.18 - $109.02 $352,032 - $383,096
-3,514 Reduced 0.66%
526,225 $57.4 Million
Q3 2023

Oct 30, 2023

BUY
$102.95 - $114.33 $1.52 Million - $1.69 Million
14,788 Added 2.87%
529,739 $54.5 Million
Q2 2023

Aug 04, 2023

BUY
$108.61 - $118.38 $3.76 Million - $4.1 Million
34,607 Added 7.2%
514,951 $59.4 Million
Q1 2023

May 02, 2023

BUY
$102.94 - $114.86 $1.95 Million - $2.18 Million
18,953 Added 4.11%
480,344 $51.1 Million
Q4 2022

Jan 26, 2023

BUY
$87.44 - $112.11 $1.52 Million - $1.95 Million
17,438 Added 3.93%
461,391 $0
Q3 2022

Oct 19, 2022

BUY
$84.53 - $94.96 $3.05 Million - $3.43 Million
36,134 Added 8.86%
443,953 $38.2 Million
Q2 2022

Jul 13, 2022

BUY
$83.49 - $94.64 $7.76 Million - $8.8 Million
92,998 Added 29.54%
407,819 $37.2 Million
Q1 2022

Apr 19, 2022

BUY
$73.51 - $82.4 $1.99 Million - $2.23 Million
27,057 Added 9.4%
314,821 $25.8 Million
Q4 2021

Jan 20, 2022

BUY
$72.28 - $90.54 $542,605 - $679,683
7,507 Added 2.68%
287,764 $22.1 Million
Q3 2021

Oct 15, 2021

SELL
$71.68 - $78.83 $427,714 - $470,378
-5,967 Reduced 2.08%
280,257 $21.1 Million
Q2 2021

Jul 19, 2021

BUY
$70.31 - $77.77 $1.36 Million - $1.5 Million
19,305 Added 7.23%
286,224 $22.3 Million
Q1 2021

May 07, 2021

BUY
$68.86 - $81.11 $35,256 - $41,528
512 Added 0.19%
266,919 $20.6 Million
Q4 2020

Feb 02, 2021

SELL
$71.77 - $79.65 $776,049 - $861,255
-10,813 Reduced 3.9%
266,407 $21.8 Million
Q3 2020

Oct 29, 2020

BUY
$73.18 - $82.95 $271,205 - $307,412
3,706 Added 1.35%
277,220 $23 Million
Q2 2020

Aug 12, 2020

BUY
$70.42 - $80.13 $800,393 - $910,757
11,366 Added 4.34%
273,514 $21.2 Million
Q1 2020

Apr 21, 2020

BUY
$63.36 - $87.82 $1.85 Million - $2.56 Million
29,147 Added 12.51%
262,148 $20.2 Million
Q4 2019

Jan 24, 2020

SELL
$77.58 - $87.54 $182,157 - $205,543
-2,348 Reduced 1.0%
233,001 $21.2 Million
Q3 2019

Oct 16, 2019

BUY
$76.08 - $82.93 $1.32 Million - $1.44 Million
17,315 Added 7.94%
235,349 $19.8 Million
Q2 2019

Aug 13, 2019

SELL
$69.84 - $81.59 $2.14 Million - $2.5 Million
-30,580 Reduced 12.3%
218,034 $18.3 Million
Q1 2019

May 07, 2019

BUY
$69.58 - $79.36 $290,148 - $330,931
4,170 Added 1.71%
248,614 $20.7 Million
Q4 2018

Jan 25, 2019

SELL
$65.24 - $75.71 $174,060 - $201,994
-2,668 Reduced 1.08%
244,444 $18.7 Million
Q3 2018

Oct 15, 2018

SELL
$57.69 - $67.84 $824,274 - $969,297
-14,288 Reduced 5.47%
247,112 $17.5 Million
Q2 2018

Jul 31, 2018

SELL
$50.83 - $59.72 $400,082 - $470,056
-7,871 Reduced 2.92%
261,400 $15.9 Million
Q1 2018

Apr 25, 2018

BUY
$50.96 - $59.23 $177,850 - $206,712
3,490 Added 1.31%
269,271 $14.7 Million
Q4 2017

Jan 25, 2018

SELL
$51.62 - $61.64 $583,615 - $696,901
-11,306 Reduced 4.08%
265,781 $15 Million
Q3 2017

Oct 27, 2017

BUY
$58.67 - $63.13 $16.3 Million - $17.5 Million
277,087
277,087 $17.7 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $244B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Sumitomo Mitsui Ds Asset Management Company, LTD Portfolio

Follow Sumitomo Mitsui Ds Asset Management Company, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Ds Asset Management Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Ds Asset Management Company, LTD with notifications on news.